MAMO vs MRNA · rev $71.8M vs rev $145.0M
Massimo Group Common Stock (MAMO) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Massimo Group Common Stock (MAMO) is a recreational vehicles company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported MAMO revenue for 2025-12-31 was $71.8M. Net income was $1.5M. Revenue was up 3680.4% from 2024-12-31 to 2025-12-31. MAMO currently screens at market cap $115.9M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
MAMO currently screens at market cap $115.9M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the MAMO and MRNA stock pages for the full models.
Not investment advice.